Webinar: GM-CSF antibody for the treatment of cytokine storm in patients with severe COVID-19

2020-04-14T21:00:35-04:00

In April, I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel or highly differentiated biologics to treat diseases with significant unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug application (IND) to initiate clinical study for TJM2 to treat cytokine release syndrome (CRS) associated with severe illness caused by the coronavirus disease 2019 (COVID-19). The Company has also obtained central institutional review board (IRB) approval from the Western Institutional Review Board on the same day. The webinar will focus on the challenges on [...]

Webinar: GM-CSF antibody for the treatment of cytokine storm in patients with severe COVID-192020-04-14T21:00:35-04:00

Verbal, Visual and Vocal: Communicating Clearly In Virtual Meetings

2020-05-03T21:00:58-04:00

The new reality of having to collaborate, share, and communicate in a virtual setting presents a new set of challenges. Whether your meetings are with or without video, you can improve your presence and communication impact by taking control of the three Vs: • Verbal: This is the words spoken – the vocabulary and grammar. • Vocal: This includes voice qualities such as intonation, volume, pace, accent interference. • Visual: This includes body language, as well as setting and context. In video conferencing, all 3 are available as clues for the listener. Without video, the Vocal becomes paramount. An excellent [...]

Verbal, Visual and Vocal: Communicating Clearly In Virtual Meetings2020-05-03T21:00:58-04:00
Toggle Sliding Bar Area
Go to Top